Subsidiaries

– DIAKINISIS S.A. WAREHOUSING – TRANSPORT- PROMO
– SAMBROOK PHARMACEUTICAL S.A.
– ELGEKA (CYPRUS) LTD
– ELGEKA – FERFELIS ROMANIA S.A.
– GATEDOOR HOLDINGS LTD
– GREC-ROM BUSINESS GROUP SRL
– SC GATEDOOR HOLDINGS COM SRL
– G.S.B.G. S.A.
– ELG HOLDINGS SINGLE-MEMBER S.A.
– ELGEKA PROPERTY & DEVELOPMENT SRL

Other Investments

– C. K. PAPADIMITRIOU S.A.
– LINETTE HELLAS S.A.
– VEDIS HOLDINGS LTD

Archives (Sold – Deleted Participations)

– MEDIHELM PHARMACEUTICAL S.A.
– ELGEKA AG
– DIAKINISIS PORT (CY) LIMITED
– DIAKINISIS PORT & SIA Ε.Ε.
– P.C.D.C. S.A.
– DIAKINISIS LOGISTICS SERVICES (CY) LTD
– VIOTROS S.A.
– ΑRIVIA S.A.
– CERA VILLA DESIGN SRL
– ELGEKA FERFELIS SRL
– ELGEKA FERFELIS BULGARIA LTD

SAMBROOK PHARMACEUTICAL S.A.REGISTERED OFFICE: MUNICIPALITY ASPROPYRGOS, ATTICA
MINISTRY OF DEVELOPMENT – GENERAL SECRETARY OF COMMERCE
(G.E.MI. NO 7164401000 – Athens Chamber of Commerce & Industry)		 Sambrook

The company provides services in the pharmaceutical and parapharmaceutical sector and produces / trades pharmaceutical products.

COMPANY CAPITAL: € 2.133.000

SHARΕHOLDER STRUCTURE %
ELGEKA S.A. 95,88%
Helen E. Metsoviti 3,67%
Alexander G. Katsiotis 0,45%

 

BOARD OF DIRECTORS
Alexander G. Katsiotis Chairman
Helen E. Metsoviti Vice Chairman & Managing Director
Aris S. Chatzatourian Member
Vasiliki K. Gatziyanni Member

 

FINANCIAL HIGHLIGHTS 2022 – 2021 ACCORDING TO I.F.R.S.

IN EURO

 2022 2021
Sales
–
–
Gross Profit / (loss)
–
–
Profit / (loss) before taxes, financing, investing activities & depreciation
 2.207,56
 (10.030,75)
Profit / (loss) before taxes, financing & investing activities
 2.207,56
 (10.030,75)
Profit / (loss) before taxes
 2.148,61
 (10.041,89)
Profit / (loss) after taxes
 (1.865,54)
 (10.706.,76)
Shareholders´ Equity
 170.764,10
 172.629,64

ADDRESS:
«Imeros Topos» Area
19300 Aspropyrgos
Tel.: +30 210 28 48 758
Fax : +30 210 28 14 308